N n dimethylformamide dmf and dichloromethane dcm for synthesis

Manufactured by Molar Chemicals

Sourced in Hungary

N,N-dimethylformamide (DMF) and dichloromethane (DCM) are commonly used solvents in chemical synthesis. DMF is a polar aprotic solvent, while DCM is a chlorinated organic solvent. These solvents can be utilized in a variety of chemical reactions and purification processes. No further extrapolation on their intended use is provided.

Automatically generated - may contain errors

Lab products found in correlation

9 fluorenylmethoxycarbonyl fmoc protected amino acid derivatives, by Iris Biotech (2 mentions) Rink amide 4 methylbenzhydrylamine rink amide mbha resin, by Iris Biotech (2 mentions) Trifluoroacetic acid tfa and solvents, by Molar Chemicals (2 mentions) Hplc grade acetonitrile, by Molar Chemicals (2 mentions) 1 hydroxybenzotriazole, by Merck Group (2 mentions) 5 6 carboxyfluorescein, by Merck Group (2 mentions) Phenol, by Merck Group (1 mentions) Piperidine, by Merck Group (1 mentions) N n diisopropylethylamine, by Merck Group (1 mentions) 1 2 ethanedithiol, by Merck Group (1 mentions) 1 8 diazabicyclo 5.4.0 undec 7 ene dbu, by Merck Group (1 mentions) Thioanisol, by Merck Group (1 mentions) Triisopropylsilane, by Merck Group (1 mentions) N diisopropylethylamine, by Merck Group (1 mentions)

Spelling variants of this product

Dichloromethane (4 citations) N,N-Dimethylformamide (DMF), dichloromethane (DCM) (3 citations) N,N-dimethylformamide (DMF), (2 citations)

2 protocols using n n dimethylformamide dmf and dichloromethane dcm for synthesis

Synthesis of Fluorescent Peptide Conjugates

Check if the same lab product or an alternative is used in the 5 most similar protocols

9-Fluorenylmethoxycarbonyl (Fmoc) protected amino acid derivatives and Rink amide 4-methylbenzhydrylamine (Rink amide MBHA) resin were purchased from IRIS Biotech GmbH (Marktredwitz, Germany). The reagents for synthesis were N,N’-diisopropylcabodiimide (DIC), N,N-diisopropyl-ethylamine (DIEA), 1-hydroxybenzotriazole (HOBt), 1,8-diazabicyclo-[5.4.0]undec-7-ene (DBU), piperidine, thioanisol, phenol, 1,2-ethanedithiol, 5(6)-carboxyfluorescein (Cf), and they were purchased from Sigma-Aldrich (Budapest, Hungary). Trifluoroacetic acid (TFA) and solvents (N,N-dimethylformamide (DMF) and dichloromethane) (DCM)) for synthesis, as well as HPLC grade acetonitrile, were obtained from Molar Chemicals (Halásztelek, Hungary). Cf-Penetratin was provided by Kata Horváti (MTA-ELTE Research Group of Peptide Chemistry; Eötvös Loránd University, Institute of Chemistry) [17 (link),18 (link)].

Bősze S., Zsila F., Biri-Kovács B., Szeder B., Majer Z., Hudecz F, & Uray K. (2020). Tailoring Uptake Efficacy of HSV-1 gD Tailoring Uptake Efficacy of Hsv-1 GD Derived Carrier Peptides. Biomolecules, 10(5), 721.

+ Open protocol

+ Expand

Synthesis of Fluorescent Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols

9-Fluorenylmethoxycarbonyl (Fmoc) protected amino acid derivatives and Rink amide 4-methylbenzhydrylamine (Rink amide MBHA) resin were purchased from IRIS Biotech GmbH (Marktredwitz, Germany). The reagents for synthesis were N,N’-diisopropylcabodiimide (DIC), N-diisopropyl-ethylamine (DIEA), 1-hydroxybenzotriazole (HOBt), 1,8-diazabicyclo-[5.4.0]undec-7-ene (DBU), piperidine, triisopropylsilane (TIS), and 5(6)-carboxyfluorescein (CF), and they were purchased from Sigma Aldrich (Budapest, Hungary). Trifluoroacetic acid (TFA) and solvents (N,N-dimethylformamide (DMF) and dichloromethane) (DCM)) for synthesis, as well as HPLC grade acetonitrile, were obtained from Molar Chemicals (Halásztelek, Hungary).

Biri-Kovács B., Adorján A., Szabó I., Szeder B., Bősze S, & Mező G. (2020). Structure–Activity Relationship of HER2 Receptor Targeting Peptide and Its Derivatives in Targeted Tumor Therapy. Biomolecules, 10(2), 183.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!